Finch Therapeutics Group, Inc., (FNCH) Social Stream



Finch Therapeutics Group, Inc., (FNCH): $2.79

0.48 (+20.78%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add FNCH to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#147 of 404

in industry

FINCH THERAPEUTICS GROUP INC (FNCH) Price Targets From Analysts

Use the tables below to see what analysts covering FINCH THERAPEUTICS GROUP INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-10 3 $34 $26 $29.666 $3.296 800.06%
2022-03-18 3 $34 $27 $30 $3.296 810.19%
2022-04-01 3 $34 $20 $27.666 $3.296 739.38%
2022-04-04 3 $20 $17 $18.5 $3.296 461.29%
2022-04-29 2 $20 $17 $18.5 $3.296 461.29%
2022-05-16 3 $17 $11 $14 $3.296 324.76%
2022-08-09 3 $20 $17 $18 $3.296 446.12%
2022-08-13 3 $17 $10 $14.666 $3.296 344.96%
2022-11-11 3 $17 $6 $13.333 $3.296 304.52%
2023-01-24 3 $17 $3 $10 $3.296 203.4%
2023-04-04 3 $7 $3 $5 $3.296 51.7%
2023-05-12 2 $210.21 $90.09 $150.15 $3.296 4455.52%
2023-08-21 2 $90.09 $10 $50.045 $3.296 1418.36%

The Trend in the Analyst Price Target


FNCH's average price target has moved up $21.05 over the prior 28 months.

Over the past 30 weeks, FNCH's average upside potential has been 8,284.42%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-24 3 90.09 90.09 90.090 0.495 18100%
2023-01-24 3 17.00 3.00 12.333 0.495 2391.52%
2023-01-24 1 17.00 3.00 10.000 0.495 1920.2%
2023-04-04 3 7.00 3.00 5.000 0.370 1251.35%
2023-05-12 2 7.00 3.00 5.000 0.358 1296.65%

FNCH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


FNCH's average broker recommendation rating improved by 0 over the prior 25 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • FINCH THERAPEUTICS GROUP INC's number of analysts covering the stock is higher than 110.09% of all US stocks.
  • FINCH THERAPEUTICS GROUP INC's upside potential (average analyst target price relative to current price) is higher than 1736% of all US stocks.
  • In terms of how FINCH THERAPEUTICS GROUP INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -624.37% of that group.
  • In the context of Healthcare stocks, FINCH THERAPEUTICS GROUP INC's average analyst price target is greater than 677.58% of them.

Stocks similar to FINCH THERAPEUTICS GROUP INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IKNA, IPSC, and AMAM.

What is the outlook for FNCH? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!